Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors

Withdrawn

• Conditions: Tracheostomy Complication

• Registration Number: NCT02074254
• Lead Sponsor: Ohio State University

Brief Summary

Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors

Detailed Description

We propose a retrospective review of our experience with bleeding complication in the presence of antiplatelet and SSRI therapy and compare the complications with those who were not on antiplatelet agents or SSRI.

Study Timeline

• Study Start: 2012-03-22
• Primary Completion: 2012-05-09
• Study Completion: 2012-05-09
• Study First Submitted: 2013-06-04
• Study First Submitted QC: 2014-02-26
• Study First Posted: 2014-02-28
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-02
• Last Update Posted: 2021-11-10

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• on antiplatelet therapy or selective serotonin reuptake inhibitors(SSRI)

Exclusion Criteria

• N/A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
a retrospective review of our experience with bleeding complication in the presence of antiplatelet and SSRI therapy and compare the complications with those who were not on antiplatelet agents or SSRI	24 months

Trial Locations

Locations (2)

OSUMC; 🇺🇸 Columbus, Ohio, United States

University Hospital, OSUMC 473 W 12th Ave; 🇺🇸 Columbus, Ohio, United States